Targeted Genetics Corporation Gene Therapy Fails to Treat Arthritis

May 30 (Reuters) - Targeted Genetics Corp's troubled gene therapy product, tgAAC94, was not effective in treating inflammatory arthritis in an early trial.
MORE ON THIS TOPIC